Published

Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non-microdosing controls

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: VIUspace
Date: 2022-06-30
Source: OpenAlex
DOI: 10.25316/ir-20556
PubMed: Unavailable

Authors

Joseph M. Rootman Maggie Kiraga Pamela Kryskow Kalin Harvey Paul Stamets Eesmyal Santos-Brault Kim P.C. Kuypers Zach Walsh

Watch author

Derived topics and classifications

psilocybin Depression Aging Microdosing Observational Study Older Adults Toxicity Observational Study

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non-microdosing controls2022-06-30

Related papers

Mood and Cognitive Effects of Low Doses of Psilocybin Observed in Healthy Subjects ("MELO"): A Blinded, Placebo-Controlled, Dose-Finding StudyClinicalTrials.gov · 2023-03-20